By Global Regulatory Submissions Inc.

Begin With the Device and Its Claims

Medical-device regulation starts with the product’s intended purpose, indications, users, operating principle, contact with the body, duration of use, software functions, and risk. A marketing description that appears minor can change classification or move a product toward a drug, combination-product, or non-device framework.

Classification drives the evidence, quality-system, registration, and review pathway. It should be documented before a launch plan, clinical strategy, or label is finalized.

Different Markets, Different Structures

Canada uses risk-based Classes I through IV. Depending on the class and activity, establishments and manufacturers may need an establishment licence, device licence, quality-system evidence, and post-market processes. The United States uses Classes I through III, with pathways that may include exemption, premarket notification under 510(k), De Novo classification, or premarket approval. In the European Union, the MDR and IVDR establish conformity-assessment, technical-documentation, economic-operator, clinical, vigilance, and registration obligations.

These systems share risk-based principles, but the classifications and evidence are not automatically interchangeable. A device can have different routes in different markets.

Build the Technical File as a System

A strong file connects device description, design and manufacturing information, risk management, verification and validation, biocompatibility, software and cybersecurity, electrical safety, usability, clinical evaluation, labelling, and post-market plans. Each claim should be traceable to appropriate evidence.

Quality management is not a one-time certificate. Document control, supplier oversight, complaint handling, corrective action, change control, vigilance, and post-market surveillance continue after launch.

Plan for Change

Design changes, new suppliers, software updates, new claims, packaging changes, and new markets may require regulatory assessment before implementation. Establish a change-assessment process that considers every jurisdiction in which the device is supplied.

Global Regulatory Submissions Inc. can support classification research, pathway planning, technical-document coordination, gap assessment, and selected application activities.

Disclaimer: This article provides general informational content and does not constitute legal, medical, toxicological, or regulatory advice. Requirements vary by product, claim, market, and jurisdiction and should be confirmed against current legislation and agency guidance.